Stockreport

Foundation Medicine Launches Whole Genome Sequencing Germline Test for Research Use to Accelerate Biopharmaceutical Research and Therapy Development Beyond Oncology [Yahoo! Finance]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF biomarker discovery and drug development across cardiometabolic, immunologic and neurologic disease areas BOSTON, March 12, 2026 BUSINESS WIRE Foundation Medicine, Inc [Read more]